ASTRAZENECA PLC (AZN)
Clinical trial NCT05417594 updates: 1. completion date: 2027-08-11 → 2027-10-13 2. primary completion date: 2027-08-11 → 2027-10-13
Clinical trial NCT05417594 updates: 1. completion date: 2027-08-11 → 2027-10-13 2. primary completion date: 2027-08-11 → 2027-10-13
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical